Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test
- 6 March 2014
- journal article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 21 (8), 1398-1403
- https://doi.org/10.1016/j.jocn.2013.11.039
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, ICT
- Future Planning, Korea (2013K000364)
- National Research Foundation (NRF)
- Korean government (MEST) (2012M3A9B6055414, 2012-0009328)
This publication has 26 references indexed in Scilit:
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years laterNeurology, 2013
- Idiopathic normal-pressure hydrocephalusNeurology, 2013
- Lumboperitoneal shunts for the treatment of normal pressure hydrocephalusJournal of Clinical Neuroscience, 2012
- Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalusAlzheimer's & Dementia, 2011
- Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathologyAnnals of Neurology, 2010
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the BrainArchives of Neurology, 2009
- CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalusActa Neurologica Scandinavica, 2007
- Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementiaThe World Journal of Biological Psychiatry, 2005
- Cerebrospinal Fluid Tau and β-AmyloidArchives of Neurology, 2003
- Alzheimer's disease, normal‐pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesisThe Lancet Neurology, 2003